AstraZeneca Airsupra Inhaler Recall: Defective Delivery System Risk
AstraZeneca recalls Airsupra inhalers with defective delivery systems. These albuterol/budesonide inhalers may not deliver medication properly. Stop using and contact for details.
Lower-risk recall
Defective delivery system
Contact the company
What happened, in plain English
AstraZeneca is recalling Airsupra inhalers that have a defective delivery system. This could mean the medication isn't delivered properly to your lungs. If you have these inhalers, stop using them and contact AstraZeneca for instructions. Read more at govinfonow.com/recall/32078-astrazeneca-airsupra-inhaler-recall-defective-delivery-system-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/32078-astrazeneca-airsupra-inhaler-recall-defective-delivery-system-risk · Updated August 17, 2026 · FDA enforcement record: FDA #D-0444-2025
Cite this page
“AstraZeneca Airsupra Inhaler Recall: Defective Delivery System Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32078-astrazeneca-airsupra-inhaler-recall-defective-delivery-system-risk. Based on FDA recall #D-0444-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0444-2025%22&limit=1).
Why it’s dangerous
The inhaler's delivery system is defective, which may cause the medication to not reach your lungs effectively. This could lead to improper treatment of respiratory conditions like asthma. However, the recall does not specify a risk of serious injury or death.
Who’s affected
People who have the Airsupra inhalers with the specific lot numbers and expiration dates listed in the recall. Those with asthma or respiratory conditions are most at risk.
How to tell if you have this one
Check the product label for the lot numbers and expiration dates listed: 120-inhalation canisters with lots 6270044C00, 6270040D00, etc., expiring through 10/2026 to 9/30/2027, or 28-inhalation canisters with lots 6270019E00, expiring 7/31/2025.
- Brand
AstraZeneca- Category
Drug
What to do — step by step
Stop Using It Now
Immediately stop using the recalled Airsupra inhalers with the specific lot numbers and expiration dates listed in the recall.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “USA Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 14 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0444-2025 (May 14, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0444-2025 to see it in context.
- Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.